Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,658,865
-
Share change
-
+1,198,172
-
Total reported value
-
$701,066,808
-
Price per share
-
$10.60
-
Number of holders
-
118
-
Value change
-
-$7,668,910
-
Number of buys
-
54
-
Number of sells
-
49
Institutional Holders of ENDOLOGIX INC - COM (ELGX) as of Q3 2014
As of 30 Sep 2014,
ENDOLOGIX INC - COM (ELGX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,658,865 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Tamarack Capital Management, LLC, Arrowpoint Asset Management, LLC, Essex Woodlands Health Ventures, Inc., DEERFIELD MANAGEMENT CO, Bank of New York Mellon Corp, PALISADE CAPITAL MANAGEMENT LLC/NJ, Clearbridge Investments, LLC, and EAGLE ASSET MANAGEMENT INC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.